US Broker Ratings

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Powerhouse with 10.7% Upside Potential

For investors seeking innovative opportunities in the healthcare sector, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands out as a formidable player in the biotechnology industry. With a..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Unlocking a 33.5% Upside Potential

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) has garnered significant attention in the healthcare sector as it continues to innovate in the biopharmaceutical space. With a market..

Vericel Corporation (VCEL) Stock Analysis: A 31.53% Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL) presents a compelling opportunity for investors eyeing the biotechnology sector, especially with a potential upside of 31.53% based on the average target..

Select Medical Holdings Corp (SEM) Stock Analysis: What Investors Need to Know About This Healthcare Provider

Select Medical Holdings Corporation (NYSE: SEM) stands at the forefront of the healthcare sector, specializing in medical care facilities across the United States. Positioned within a..

PGIM Securitized Income ETF (PINC): A Steady Performer in the Securitized Credit Space

The PGIM Securitized Income ETF (NYSE: PINC) is steadily gaining attention in the investment community, not through flashy price swings or speculative buzz, but through its..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Discovering a 56% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the medical devices sector, presents an intriguing investment opportunity with a potential upside of 56.23%. This Carlsbad,..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Revenue Growth Surges by 2,873% Amidst Strong Biotech Potential

Crinetics Pharmaceuticals, Inc. (CRNX) has captured significant attention within the biotechnology sector, standing out with a remarkable revenue growth rate of 2,873.40%. This San Diego-based clinical-stage..

Perrigo Company plc (PRGO) Stock Analysis: A Deep Dive into Its 54.49% Potential Upside

Perrigo Company plc (NASDAQ: PRGO), a stalwart in the healthcare sector, is currently presenting an intriguing opportunity for investors seeking exposure in the drug manufacturing industry,..

Privia Health Group, Inc. (PRVA) Investor Outlook: Exploring a Potential 34% Upside

Privia Health Group, Inc. (NASDAQ: PRVA), a burgeoning player in the healthcare sector, is drawing significant attention from investors eager to capitalize on its promising growth..

Clover Health Investments Corp (CLOV) Stock Analysis: Navigating the 62% Revenue Surge and Future Prospects

Clover Health Investments Corp (NASDAQ: CLOV), an innovative player in the healthcare sector, is capturing investor attention with its impressive revenue growth and strategic positioning. As..

Enovis Corporation (ENOV) Stock Analysis: Healthcare Innovator Poised for 32% Upside

Enovis Corporation (NYSE: ENOV), a notable player in the healthcare sector, has carved a niche for itself within the medical devices industry, providing cutting-edge solutions for..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech Pioneer with Robust Revenue Growth and Promising Pipeline

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands at the forefront of the biotechnology sector with an impressive market capitalization of $8.51 billion. The company, headquartered in Newark,..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 77% Potential Upside in the Healthcare Sector

NovoCure Limited (NASDAQ: NVCR), a prominent player in the healthcare sector, has captured investor attention with its innovative approach to cancer treatment through Tumor Treating Fields..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Evaluating a Robust 7.43% Potential Upside

Amneal Pharmaceuticals, Inc. (AMRX), a key player in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry, commands a significant presence in..

Envista Holdings Corporation (NVST) Stock Analysis: Exploring a 7.52% Potential Upside in the Dental Market

Envista Holdings Corporation (NYSE: NVST) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $4.45..

Haemonetics Corporation (HAE) Stock Analysis: Strong Buy Ratings Propel Healthcare Innovator Amid 87.90 Target Price

Haemonetics Corporation (NYSE: HAE), a leader in medical technology specializing in blood management solutions, is capturing the attention of investors with its robust growth potential and..

LifeStance Health Group, Inc. (LFST) Investor Outlook: Analyzing the 13.85% Potential Upside

LifeStance Health Group, Inc. (LFST), a prominent player in the U.S. healthcare sector, has been making waves in the outpatient mental health services industry. With a..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A 25% Upside in Biotech Innovation

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is capturing the attention of investors as it navigates the dynamic landscape of biotechnology. With a focus on developing RNA interference-based..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Evaluating Its 5.04% Dividend Yield Amidst Market Challenges

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a notable player in the healthcare sector, particularly in the medical instruments and supplies industry, has been generating interest among investors..

ImmunityBio, Inc. (IBRX) Stock Analysis: Assessing a 78% Potential Upside in Cutting-Edge Immunotherapy

ImmunityBio, Inc. (NASDAQ: IBRX) is catching the eyes of investors with its promising strides in the biotechnology sector, focusing on next-generation immunotherapies. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds